Expression of the tyrosine kinase c‐kit is an independent prognostic factor in patients with small cell lung cancer
暂无分享,去创建一个
U. Steidl | H. Geddert | H. Gabbert | W. Müller | U. Germing | U. Rohr | R. Fenk | R. Haas | R. Kronenwett | M. Schott | N. Rehfeld | Lucy Pflugfelder | T. Gräf | K. Thiele | W. Müller
[1] M. Tsao,et al. Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] A. Potti,et al. CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[3] J. Verweij,et al. Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens. , 2003, European journal of cancer.
[4] F. Oesch,et al. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[5] S. Alkan,et al. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis. , 2002, Human pathology.
[6] G. Demetri,et al. Management of malignant gastrointestinal stromal tumours. , 2002, The Lancet. Oncology.
[7] J. Fletcher,et al. Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. , 2002, Human pathology.
[8] S. Honsawek,et al. The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] R. Salgia,et al. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571 , 2000, Oncogene.
[10] C. Mountain,et al. The international system for staging lung cancer. , 2000, Seminars in surgical oncology.
[11] J. Lasota,et al. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. , 1999, The American journal of pathology.
[12] M. Yamakido,et al. Specific Growth Inhibition of Small‐cell Lung Cancer Cells by Adenovirus Vector Expressing Antisense c‐kit Transcripts , 1996, Japanese journal of cancer research : Gann.
[13] G. Krystal,et al. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. , 1996, Cancer research.
[14] E. Thiel,et al. Recombinant human stem cell factor does exert minor stimulation of growth in small cell lung cancer and melanoma cell lines. , 1995, European journal of cancer.
[15] R. Ueda,et al. Ectopic expression of c‐kit in small‐cell lung cancer , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[16] T. Tsukamoto,et al. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. , 1993, Cancer research.
[17] T. Nakamura,et al. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. , 1993, British Journal of Cancer.
[18] A. Ullrich,et al. Expression of c-kit receptor in normal and transformed human nonlymphoid tissues. , 1992, Cancer research.
[19] T Takahashi,et al. Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. , 1991, Oncogene.
[20] R. Ueda,et al. Preferential expression of c-kit protooncogene transcripts in small cell lung cancer. , 1991, Cancer research.